GlassScriptPhysician profile
Mitchell F Dunklebarger
NPI 1205399177
$2,292.33
in general payments reported to CMS, 2019-2025
12 companies · $934 in 2025
The $934 reported for 2025 was more than what 78% of Otolaryngology providers received nationally (typical 2025 total: $317).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $67.09 · 2022: $138 · 2023: $150 · 2024: $1,004 · 2025: $934.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,793 · Education: $294.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,793.18 |
| Education | $293.99 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Stryker Corporation | $529.08 | 2021-2025 | Na, Core, Colorado |
| Integra Lifesciences Corporation | $513.13 | 2024-2025 | Integra, Integra Dermal Regeneration Template, Primatrix |
| Medical Device Business Services, INC. | $366.50 | 2024 | Vistaseal |
| Inspire Medical Systems, INC. | $200.72 | 2024-2025 | Inspire |
| Polynovo North America LLC | $164.48 | 2025 | Novosorb Btm |
| Baxter Healthcare | $151.02 | 2025 | Tisseel |
| Avita Medical Americas, LLC | $150.00 | 2024 | |
| Lifenet Health | $116.77 | 2022 | |
| Musculoskeletal Transplant Foundation INC. | $56.34 | 2025 | |
| Abbvie INC. | $22.99 | 2024 | |
| Depuy Synthes Sales INC. | $13.88 | 2022 | |
| Ambu INC. | $7.42 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Mitchell Dunklebarger listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.